Navigation Links
Ardea to Present at Cowen and Company's 28th Annual Health Care Conference
Date:3/11/2008

SAN DIEGO, March 11 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc. (Nasdaq: RDEA) today announced that Barry D. Quart, PharmD, President and CEO of Ardea Biosciences, will present at Cowen and Company's 28th Annual Health Care Conference.

Date: Tuesday, March 18, 2008

Time: 4:40 p.m. Eastern Time

Location: The Boston Marriott Copley Place Hotel, Boston, MA

Webcast:

http://www.corporate-ir.net/ireye/conflobby.zhtml?ticker=RDEA&item_id=1 779991

About Ardea Biosciences, Inc.

Ardea Biosciences of San Diego, California is a biotechnology company focused on the discovery and development of small-molecule therapeutics in virology, oncology and inflammation. The Company has two product candidates in clinical development and several others in preclinical development. Ardea's most advanced clinical development candidate is RDEA806, a non-nucleoside reverse transcriptase inhibitor (NNRTI), which is in a Phase 2a study for the treatment of HIV. In addition, the Company is investigating RDEA806 for the treatment of gout. The Company's lead mitogen-activated ERK kinase (MEK) inhibitor, RDEA119, is in a Phase 1 study in advanced cancer patients and is being investigated for the treatment of inflammatory diseases. Ardea also is developing a next-generation NNRTI for HIV and a next-generation MEK inhibitor for both cancer and inflammatory diseases.

Statements contained in this press release regarding matters that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Because such statements are subject to risks and uncert
'/>"/>

SOURCE Ardea Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Selection of Development Candidate Triggers $0.5 Million Milestone Payment to Ardea Biosciences, Inc.
2. Ardea Biosciences Announces Changes to Research Management
3. Ardea Biosciences, Inc. Reports Third Quarter 2007 Operating and Financial Results
4. Ardea Biosciences to Participate in RBC Capital Markets 2007 Healthcare Conference
5. Ardea Biosciences Announces $40 Million Private Placement
6. Ardea Biosciences to Present Preclinical Data on Three HIV Non-Nucleoside Reverse Transcriptase Inhibitors During 15th Annual Conference on Retroviruses and Opportunistic Infections
7. Ardea Biosciences Establishes Scientific Advisory Board for HIV Program
8. Ardea Biosciences to Present at Roth Capital Partners 20th Annual OC Growth Stock Conference
9. Ardea Biosciences Establishes Scientific Advisory Board for Inflammation Program
10. Ardea Biosciences to Move Headquarters and R&D Laboratories to San Diego
11. Imagenetix Inc. to Present at Noble Small Cap Financial Conference on August 21, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... company,s revenues increase 22% for fiscal 2009; on ... , TORONTO, Dec. 16 /PRNewswire-FirstCall/ - Microbix Biosystems ... and biological technologies, today reported financial results for ... year ended September 30, 2009, Microbix reported revenues ... same period in 2008. For fourth-quarter 2009, the ...
(Date:12/16/2009)... Eppendorf has initiated an,import ban ... systems for,infringement of European patent EP 1 ... and/or the quantification of a target compound". ... of the respective products into any country ... to confiscate any,violating products. , ...
(Date:12/15/2009)... Institute (JBEI), one of three Department of Energy (DOE) ... service to protect its valuable intellectual property. , ... ... December 15, 2009 -- Surety, LLC , the ... today announced that the Joint BioEnergy Institute (JBEI), one ...
(Date:12/15/2009)... Medical, Inc. (OTC Bulletin Board : AEMD) announced ... Comper have joined the Science Advisory ... Schorey and Dr. Comper are leading researchers in ... of Aethlon Medical, was recently formed to leverage ... being advanced as an adjunct therapy for Hepatitis-C ...
Breaking Biology Technology:Microbix' Pipeline Set To Reach Milestones In 2010 2Microbix' Pipeline Set To Reach Milestones In 2010 3Microbix' Pipeline Set To Reach Milestones In 2010 4Microbix' Pipeline Set To Reach Milestones In 2010 5Microbix' Pipeline Set To Reach Milestones In 2010 6Microbix' Pipeline Set To Reach Milestones In 2010 7Microbix' Pipeline Set To Reach Milestones In 2010 8Eppendorf Successfully Initiates Import ban Against Nanosphere, Inc. for the Countries of the European Union 2Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 2Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 3Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 4Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 5Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 2Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 3Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 4Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 5
... ImQuest Life Sciences today presented important new results ... inhibitor of HIV-1 at the 16th CROI meeting ... the advanced development of ImQuest,s lead HIV pyrimidinedione ... of HIV, exhibiting a dual mechanism of action ...
... regulatory filings for S0812 and additional promising bitter ... Inc. (Nasdaq: SNMX ), a leading ... and develop novel flavor ingredients for the food, ... it has initiated development activities for S0812 and ...
... In a paper,published today, scientists at deCODE genetics ... continents present a novel insight into the connection,between ... in some,10,000 Icelanders, the deCODE team discovered several ... genome (SNPs) that increase levels of,eosinophils in the ...
Other Biology Technology:ImQuest Presents IND-Enabling Safety Pharmacology and Pharmacokinetic Data for the Therapeutic HIV Compound IQP-0410 at Conference on Retroviruses and Opportunistic Infections 2SENOMYX ANNOUNCES INITIATION OF DEVELOPMENT ACTIVITIES FOR NEW BITTER BLOCKERS 2SENOMYX ANNOUNCES INITIATION OF DEVELOPMENT ACTIVITIES FOR NEW BITTER BLOCKERS 3SENOMYX ANNOUNCES INITIATION OF DEVELOPMENT ACTIVITIES FOR NEW BITTER BLOCKERS 4Multinational deCODE Study Identifies New Link Between Inflammation and Heart Attack 2Multinational deCODE Study Identifies New Link Between Inflammation and Heart Attack 3Multinational deCODE Study Identifies New Link Between Inflammation and Heart Attack 4
(Date:12/16/2009)... molecules form an intricate network of interactions. Today,s ... individual molecular reactions outside the cells. Since molecular ... the laboratory, scientists suspect that the kinetics of ... external probes. We expected the cellular reaction speed ... Braun. "However, our novel optical approach showed that ...
(Date:12/16/2009)... Hill, CA Tom Bowman, an expert in communicating ... Global Change, has developed a series of graphics that ... Climate Change (IPCC) report for public audiences. These new ... they need to make informed decisions about climate change ... as a means to clearly and accurately communicate findings ...
(Date:12/16/2009)... -- DigitalPersona, Inc., a leader in fingerprint ... agreement with IBM to deploy a new ... on IBM SurePOS 500 retail systems. The ... to more easily and quickly identify users ... to the individuals who perform them. ...
Breaking Biology News(10 mins):Looking for the heartbeat of cellular networks 2Bowman creates graphic translation of climate change data 2DigitalPersona Fingerprint Sensor Technology Ships on IBM SurePOS 500 Retail Systems 2Senators Gregg and Shaheen Vote to Protect Americas Kids From Tobacco 48699 1Senators Gregg and Shaheen Vote to Protect Americas Kids From Tobacco 48699 2Senator Bill Nelson Votes to Protect Americas Kids from Tobacco 48696 1Senator Bill Nelson Votes to Protect Americas Kids from Tobacco 48696 2Senators Specter and Casey Vote to Protect Americas Kids from Tobacco 48693 1Senators Specter and Casey Vote to Protect Americas Kids from Tobacco 48693 2
... chicken when she crossed the road is less important that what ... , Organic arsenic is fed to poultry to prevent bacterial infections ... up by the tissue and the majority of it is excreted ... urine from under poultry houses -- is rich in nitrogen and ...
... prediction of patient outcomes, lead to tailored treatmentsWhen it ... can be deadly. In some severely injured patients, this ... response, including bloodstream infection (sepsis) and multiple organ failure. ... is still mysterious, so doctors can't accurately predict how ...
... Russia, not the least of which is a very ... 25- to 54-year-old Russian men living in an industrial ... "surrogate" alcohols, otherwise known as products containing alcohol that ... now analyzed the contents of these surrogate alcohol products, ...
Other Biology News:New class of antibiotics effective against drug-resistant bacteria discovered in fungi 2Study Unlocks Insects?Secret for Love in the Dark 2Study Unlocks Insects?Secret for Love in the Dark 3Russian 'surrogate' alcohols are a killer 2Russian 'surrogate' alcohols are a killer 3Russian 'surrogate' alcohols are a killer 4
RABBIT ANTI TRANSFERRIN RECEPTOR...
ANTI FLAG EP CL VEC...
EGTA, 10 g. Ethylene glycol-O,O-bis-[2-amino-ethyl]-N,N,N,N,-tetraacetic acid.Assay: > 99.0%. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
casein kinase 2, alpha 1 polypeptide, transcript variant 2, mRNA (cDNA clone MGC:15232 IMAGE:4121882), complete cds...
Biology Products: